Potassium iodide in refractory, recurrent pediatric Sweet syndrome: Guidance in dosing and monitoring.

Abstract

We describe a 5-month-old boy with clinical and histopathologic presentation of Sweet syndrome. He responded to systemic corticosteroids, with multiple flares on tapering; potassium iodide was added, which provided complete resolution of Sweet syndrome. Potassium iodide has been used in only a few cases, and no standard dosage has been established in children. We discuss calculation of a pediatric dosage for potassium iodide in Sweet syndrome.

• Authors: Jennifer Aileen Ang Tangtatco, Nhung Ho, Aaron Drucker, Catherine Forse
• Journal: Pediatric dermatology (Pediatr Dermatol) Vol. 35 Issue 2 Pg. 271-273 (Mar 2018) ISSN: 1525-1470 [Electronic] United States
• PMID: 29314271 (Publication Type: Case Reports, Journal Article)
• Copyright: © 2018 Wiley Periodicals, Inc.

Chemical References

• Glucocorticoids
• Potassium Iodide

Topics

• Glucocorticoids (therapeutic use)
• Humans
• Infant
• Male
• Potassium Iodide (administration & dosage)
• Recurrence
• Skin (pathology)
• Sweet Syndrome (diagnosis, drug therapy)
• Treatment Outcome